Virus Genes

, Volume 28, Issue 1, pp 85–97 | Cite as

Genetic Vaccination of Mice with Plasmids Encoding the NS1 Non-structural Protein from Tick-borne Encephalitis Virus and Dengue 2 Virus

Article

Abstract

Although there is a safe, inexpensive and efficacious vaccine against yellow fever, vaccination against other flavivirus diseases is less successful. There is no licensed vaccine against dengue fever and current vaccines against tick-borne encephalitis (TBE) and Japanese encephalitis are expensive and require several injections. Furthermore novel vaccines containing only virus envelope proteins may raise fears over antibody mediated enhancement (ADE) of disease. Here we report the successful use of genetic vaccination against TBE in an experimental animal model using a plasmid containing the coding sequence of a non-structural protein (NS1). Such vaccines would provide inexpensive protection against disease, without raising concerns over inducing ADE on subsequent exposure to heterotypic infectious virus. Attempts to generate chaemeric plasmids to protect against both TBE and dengue fever were less successful. Although these chaemeric plasmids directed the synthesis and secretion of the virus NS1 protein normally, no protection was observed against either TBE or dengue fever.

flavivirus naked DNA non-structural virus proteins tick-borneencephalitis vaccine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chambers T.J., Hahn C.S., Galler R., and Rice, C.M., Ann Rev Microbiol 44, 649–688, 1990.Google Scholar
  2. 2.
    Monath T.P. and Heinz F.X., in Fields B.N., Knipe D.M., and Howley P.M. (eds), Fields'Virology, 3rd edn. Lippincott, and Raven, Philadelphia, 1996, pp. 961–1034.Google Scholar
  3. 3.
    Stephenson J.R., Vaccine 6, 471–480, 1988.Google Scholar
  4. 4.
    Freestone D.S., Ferris R.D., Weinberg A.L., and Kelly, J Biol Standard 5, 181–186, 1997.Google Scholar
  5. 5.
    Heinz F.X., Kunz C., and Fauma H., J Med Virol 6, 213–221, 1980.Google Scholar
  6. 6.
    Popov O.V., Sumarakov A.A., Shkol'nik R.Ya., El'bert L.B., Vorob'era M.A., and Krutyanskaya G.L., Zh. Mikrobiol Epidemiol Immunobiol 62, 34–39, 1985.Google Scholar
  7. 7.
    Klockmann U., Bock H.L., Franke V., Hein B. Reiner G., and Hilfenhaus J., J Biol Standard 17, 331–337, 1989Google Scholar
  8. 8.
    Takaku K., Yamashita T., Osanai T., Yoshida I., Kato M., and Goda H., Biken J 11, 25–38, 1968.Google Scholar
  9. 9.
    Brotherston J.G., and Boyce J.B., Vet Rec 84, 514–515, 1969.Google Scholar
  10. 10.
    Huang C.H., Adv Virus Res 27, 71–101, 1982.Google Scholar
  11. 11.
    Halstead S.B., and Deen J., Lancet 360, 1243–1245, 2002.Google Scholar
  12. 12.
    Kanesa-thasan N., Sun W., Kim-Ahn G., Van-Albert S., Putnak J.R., King A., Raengsakulsrach B., Christ-Schmidt H., Gilson K., Zahradnik J.M., Vaughn D.W., Innis B.L., Saluzzo J.F., and Hoke C.H. (Jr),Vaccine 19, 3179–3188, 2001.Google Scholar
  13. 13.
    Guzman M.G., Kouri G., Valdes L., Bravo J., Alvarez M., Vazques S., Delgado I., and Halstead S.B., Am J Epidemiol 152, 793–799, 2000.Google Scholar
  14. 14.
    Vaughn D.W., Am J Epid 152, 800–803, 2000.Google Scholar
  15. 15.
    Cardosa M.J., Br Med Bull 54, 395–407, 1998.Google Scholar
  16. 16.
    Halstead S.B., Prog Allergy 31, 301–364, 1982.Google Scholar
  17. 17.
    Peiris J.S.M., and Porterfield J.S., J Gen Virol 58, 291–296, 1982.Google Scholar
  18. 18.
    Phillpotts R.J., Stephenson J.R., and Porterfield J.S., J Gen Virol 66, 1831–1837, 1985.Google Scholar
  19. 19.
    Halstead S.B., J Inf Dis 140, 527–533, 1979.Google Scholar
  20. 20.
    Mathew A., Kurane I., Rothman A.L., Zeng L.L., Brinton M.A., and Ennis F.A., J Clin Invest 98, 1684–1691, 1996.Google Scholar
  21. 21.
    Mathew A., Kurane I., Green S., Stephens H.A., Vaughn D.W., Kalayanarooj S., Suntayakorn S., Chandanayingyong D., Ennis F.A., and Rothman A.L., J Virol 72, 3999–4004, 1998.Google Scholar
  22. 22.
    Parrish C.L., Coa G., Hill A., Muellbacher A., Westaway E.G., and Blanden R.V., J Gen Virol 72, 1645–1653, 1991.Google Scholar
  23. 23.
    Rothman A.L., Kurane I., Lai C.-J., Bray M., Falgout B., Men R., and Ennis F.A., J Virol 67, 801–806, 1993.Google Scholar
  24. 24.
    Lobigs M., Arthur C.E., Muellbacher A., and Blanden R.V., Virology 202, 195–201, 1994.Google Scholar
  25. 25.
    Bukowski J.F., Kurane I., Lai C.-J., Bray M., Falgout B., and Ennis F.A., J Virol 63, 5086–5091, 1989.Google Scholar
  26. 26.
    Kurane I., Meager A., and Ennis F.A., J Exp Med 170, 763–775, 1989.Google Scholar
  27. 27.
    Kurane I., Brinton M.A., Samson A.L., and Ennis F.A., J Virol 65, 1825–1828, 1991.Google Scholar
  28. 28.
    Cardiff R.D., McCloud T.G., and Russell P.K., Virology 41, 569–572, 1970.Google Scholar
  29. 29.
    Falker W.A., (Jr.) Diwan A.R., and Halstead S.B., J Immunol 111, 1804–1809, 1973.Google Scholar
  30. 30.
    Schlesinger J.J., Brandriss M.W., Cropp C.B., and Monath T.P., Virology 60, 1153–1155, 1986.Google Scholar
  31. 31.
    Schlesinger J.J., Brandiss M.W., and Walsh E.E., J Immunol 135, 2805–2809, 1985.Google Scholar
  32. 32.
    Gould E.A., Buckley A., Barrett A.D.T., and Cammack N., J Gen Virol 67, 591–595, 1986.Google Scholar
  33. 33.
    Jacobs S.C., Wilkinson G.W.G., and Stephenson J.R., J Virol 66, 2086–2095, 1992.Google Scholar
  34. 34.
    Jacobs S.C., Stephenson J.R., and Wilkinson G.W.G., J Gen Virol 75, 2399–2402, 1994.Google Scholar
  35. 35.
    Timofeev A.V., Ozherelkov S.V., Pronin A.V., Deeva A.V., Karganova G.G., Elbert L.B., and Stephenson J.R., J Gen Virol 79, 689–695, 1998.Google Scholar
  36. 36.
    Stephenson J.R., Curr Pharmaceutical Biotech 2, 47–76, 2001.Google Scholar
  37. 37.
    Kochel T.J., Wu S.J., Raviprakash K., Hobart P., Hoffman S., Porter K., and Hayes C., Vaccine 15, 547–552, 1997.Google Scholar
  38. 38.
    Porter K.R., Kochel T.J., Wu S.J., Raviprakash K., Phillips I., and Hayes C.G., Arch Virol 143, 997–1003, 1998.Google Scholar
  39. 39.
    Simmons M., Murphy G.S., Kochel T., Raviprakash K., and Hayes C.G., Am J Trop Med Hyg 65, 420–426, 2001.Google Scholar
  40. 40.
    Raviprakesh K., Porter K.R., Kochel T.J., Ewing D., Simmons M., Phillips I., Murphy G.S., Weiss W.R., and Hayes C.G., J Gen Virol 81, 1659–1667, 2000.Google Scholar
  41. 41.
    Konishi E., Yamaoka M., Kurane I., and Mason P.W., Vaccine 18, 1133–1139, 2000.Google Scholar
  42. 42.
    Lin Y.L., Chen L.K., Liao C.L., Yeh C.T., Ma S.H., Chen J.L., Huang Y.L., Chen S.S., and Chiang H.Y., J Virol 72, 191–200, 1998.Google Scholar
  43. 43.
    Konishi E., Yamaoka M., Khin-Sane-Win, Kurane I., and Mason P.W., J Virol 72, 4925–4930, 1998.Google Scholar
  44. 44.
    Pan C.H., Chen H.W., Huang H.W., and Tao M.H., J Virol 75, 11457–11463, 2001.Google Scholar
  45. 45.
    Chang G.J., Hunt A.R., and Davis B., J Virol 74, 4244–4252, 2000.Google Scholar
  46. 46.
    Takada K., Masaki H., Konishi E., Takahashi M., and Kurane I., Arch Virol 145, 523–534, 2000.Google Scholar
  47. 47.
    Chen H.W., Pan C.H., Liau M.Y., Jou R., Tsai C.J., Wu H.J., Li Y.L., and Tao M.H., J Virol 73, 10137–10145, 1999.Google Scholar
  48. 48.
    Ashok M.S., and Rangarajan P.N., Vaccine 18, 68–75, 1999.Google Scholar
  49. 49.
    Konishi E., Tamaoka M., Khin-Sane-Win, Kurane I., Takada K., and Mason P.W., J Virol 73, 5527–5534, 1999.Google Scholar
  50. 50.
    Colombage G., Hall R., Pavy M., and Lobigs M., Virology 250, 151–163, 1998.Google Scholar
  51. 51.
    Davis B.S., Chang G.J., Cropp B., Roehrig J.T., Martin D.A., Mitchell C.J., Bowen R., and Bunning M.L., J Virol 75, 4040–4047, 2001.Google Scholar
  52. 52.
    Aberle J.H., Aberle S.W., Allison S.L., Stiasny K., Ecker M., Mandl C.W., Berger R., and Heinz F.X., J Immunol 163, 6756–6761, 1999.Google Scholar
  53. 53.
    Fleeton M.N., Liljestrom P., Sheahan B.J., and Atkins G.J., J Gen Virol 81, 749–758, 2000.Google Scholar
  54. 54.
    Konishi E., Yamaoka M., Kurane I., and Mason P.W., Virology 268, 49–55, 2000.Google Scholar
  55. 55.
    Nam J.H., Cha S.L., and Cho H.W., Microbiol Immunol 46, 23–28, 2002.Google Scholar
  56. 56.
    Monath T.P., Arroyo J., Miller C., and Guirakhoo F., Curr Drug Targets Infect Disord 1, 37–50, 2001.Google Scholar
  57. 57.
    Raviprakash K., Kochel T.J., Ewing D., Simmons M., Phillips, Hayes C.G., and Porter K.R., Vaccine 18, 2426–2434, 2000.Google Scholar
  58. 58.
    Kochel T.J., Raviprakash K., Hayes C.G., Watts D.M., Russell K.L., Gozalo A.S., Phillips I.A., Ewing D.F., Murphy G.S., and Porter K.R., Vaccine 18, 3166–3173, 2000.Google Scholar
  59. 59.
    Schmaljohn C., Custer D., Vander-Zanden L., Spik K., Rossi C., and Bray M., Virology 263, 166–174, 1999.Google Scholar
  60. 60.
    Monath T.P., Curr Top Microbiol Immunol 267, 105–138, 2002.Google Scholar
  61. 61.
    Chang G.J., Davis B.S., Hunt A.R., Holmes D.A., and Kuno G., Ann NY Acad Sci 951, 272–285, 2001.Google Scholar
  62. 62.
    Kinney R.M., and Huang C.Y., Intervirology 44, 176–197, 2001.Google Scholar
  63. 63.
    Morozova O.V., Maksimova T.G., and Bakhvalova V.N., Viral Immunol 12, 277–280, 1999Google Scholar
  64. 64.
    Gilbert H.J., Clarke I.N., Gibson R.K., Stephenson J.R., and Tully M., J. Bact 161, 314–320, 1985.Google Scholar
  65. 65.
    Sambrook J., and Russell D.W., Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbour Press.Google Scholar
  66. 66.
    Qu et al., J Gen Virol 1993, 74, pp. 89–97.Google Scholar
  67. 67.
    Mandl C.W., Heinz F.X., Stockl E., and Kunz C., Virology 173, 291–301, 1989.Google Scholar
  68. 68.
    Stephenson J.R., Crooks A.J., and Lee J.M., J Gen Virol 68, 1307–1316, 1987.Google Scholar
  69. 69.
    Stephenson J.R., Wilton-Smith P., and Lee J.M., J Gen Virol 65, 81–89, 1984.Google Scholar
  70. 70.
    Crooks A.J., Lee J.M., Easterbrook L.M., Timofeev A.V., and Stephenson J.R., J Gen Virol 75, 3453–3460, 1994.Google Scholar
  71. 71.
    Lee J.M., Crooks A.J., and Stephenson J.R., J Gen Virol 70, 335–343, 1989.Google Scholar
  72. 72.
    Hambleton P., Stephenson J.R., Baskerville A., and Wiblin C.N., Inf Immun 40, 995–1003, 1983.Google Scholar
  73. 73.
    Kelley L.A., MacCallum R.M., and Sternberg M.J.E., J Mol Biol 299, 499–520, 2000.Google Scholar
  74. 74.
    Fooks A.R., Sharpe S.A., Shallcross J.A., Clegg J.C., and Cranage M.P., Dev Biol 104, 65–71, 2000.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  1. 1.Chumakov Institute of Poliomyelitis and Viral Encephalitis RAMSMoscow RegionRussia
  2. 2.Ivanovsky Institute of Virology RAMSMoscowRussia
  3. 3.London School of Hygiene and Tropical MedicineLondonUK

Personalised recommendations